Compare · MDLN vs NYXH
MDLN vs NYXH
Side-by-side comparison of Medline Inc. (MDLN) and Nyxoah SA (NYXH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and NYXH operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $50.91B, about 832.8x NYXH ($61.1M).
- Over the past year, MDLN is down 4.8% and NYXH is down 80.1% - MDLN leads by 75.3 points.
- MDLN has been more active in the news (4 items in the past 4 weeks vs 2 for NYXH).
- MDLN has more recent analyst coverage (25 ratings vs 9 for NYXH).
PerformanceMDLN-4.83%NYXH-70.61%
2025-12-17+0.00%2026-07-24
- Company
- Medline Inc.
- Nyxoah SA
- Price
- $38.78+3.02%
- $1.41-3.77%
- Market cap
- $50.91B
- $61.1M
- 1M return
- +7.57%
- -13.27%
- 1Y return
- -4.83%
- -80.09%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2021
- News (4w)
- 4
- 2
- Recent ratings
- 25
- 9
NYXH
Nyxoah SA
Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. It offers Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treast moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium.
Latest MDLN
- Medline strengthens California distribution network with new 1 million-square-foot facility in Perris
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
Latest NYXH
- SEC Form 6-K filed by Nyxoah SA
- Nyxoah Announces Preliminary Results for the Second Quarter of 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by Nyxoah SA
- Information on the total number of voting rights and shares
- Publication relating to transparency notifications
- SEC Form 6-K filed by Nyxoah SA
- Nyxoah to Host Investor Day in New York on July 8, 2026
- SEC Form SCHEDULE 13G filed by Nyxoah SA
- Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026
- Publication relating to transparency notifications